Group 1 - The core viewpoint of the article highlights the significant decline in the financial performance of Da Health International, with a reported revenue drop of 34.7% year-on-year [1] - The company reported a revenue of approximately HKD 711.5 million for the fiscal year ending June 30, 2025, alongside a gross profit of about HKD 113.4 million, reflecting a decrease of 37% year-on-year [1] - Da Health International experienced a loss attributable to shareholders of HKD 26.06 million, marking a shift from profit to loss compared to the previous year, with a loss per share of HKD 0.3246 [1] Group 2 - The decline in revenue is primarily attributed to the impact of new healthcare policies in China and a decrease in the number of active customers within the national distribution network [1] - On January 28, shareholders transferred shares from Futu Securities International Hong Kong to Baoxin Securities, with a transfer value of HKD 30.35 million, representing 5.48% of the company's market capitalization [1]
大健康国际(02211)股东将股票由富途证券国际香港转入宝新证券 转仓市值3035.37万港元